| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 02/23/2000 | CN1245424A Medicinal composition |
| 02/23/2000 | CN1245423A Formulation and method for treating neoplasms by inhalation |
| 02/23/2000 | CN1245421A Gel compositions containing gellants in form of alkyl amides of tri-carboxylic acids |
| 02/23/2000 | CN1245394A Skin product having continuing antimicrobial, antiviral, antiseptic, and healing properties |
| 02/23/2000 | CN1245161A Process for preparing chromium L-threonate, its preparing process and application |
| 02/23/2000 | CN1245072A Ointment for treating burn and scald and its preparing process |
| 02/23/2000 | CN1245062A Chinese-medicinal contraceptive able to make kidney stronger |
| 02/23/2000 | CN1245059A Arginomycin medicine for vagina |
| 02/23/2000 | CN1245056A Solid skin-testing agent of cephalosporins |
| 02/23/2000 | CN1245055A Oral medicine |
| 02/23/2000 | CN1245054A Cosmetics and/or composition for treating skin disease and use thereof |
| 02/23/2000 | CN1049600C Chinese herbal medicine oral liquid for curing wind-heat common cold and its preparing method |
| 02/23/2000 | CN1049595C Hematopoietic table and producing process thereof |
| 02/23/2000 | CN1049593C Liniment for treatment of osteoproliferation |
| 02/23/2000 | CN1049589C Vulneary for promoting healing of wound |
| 02/23/2000 | CN1049581C Oral capsule with adsorption of urea-nitrogen |
| 02/23/2000 | CN1049576C Hard porous foam embolus and its manufacturing technology |
| 02/22/2000 | US6028198 Pharmaceutical composition for prevention and treatment of motion sickness syndrome |
| 02/22/2000 | US6028164 Bioresorbable compositions for implantable prostheses |
| 02/22/2000 | US6028108 Propofol composition comprising pentetate |
| 02/22/2000 | US6028105 Topical drug delivery composition and method |
| 02/22/2000 | US6028098 Use of cis-or transurocamic acid for the treatment of photodermatoses and immunogenic skin diseases |
| 02/22/2000 | US6028067 As immunosuppressant |
| 02/22/2000 | US6028066 For delivering higher concentrations of bioactive agents to improve efficacy of the bioactive agents |
| 02/22/2000 | US6028065 As anticarcinogenic agent |
| 02/22/2000 | US6028057 Inducing pseudopregnancy in fertile female pigs comprising administering to the pigs an effective amount of a compound that induces pseudopregnancy in a biodegradable controlled release formulation |
| 02/22/2000 | US6027748 Of drugs exhibiting a different biological absorption rate in the presence and in the absence of food; comprising a core having one or a core having layers of erodible, gellable hydrophilic polymer barriers; acid-resistant coating |
| 02/22/2000 | US6027747 Process for the production of dry pharmaceutical forms and the thus obtained pharmaceutical compositions |
| 02/22/2000 | US6027746 Oral drug delivery system comprising a liquid pharmaceutical suspension of an unpleasant tasting drug and an absorber particle (a silica) dispersed in an aqueous or nonaqueous carrier solvent encapsulated in a soft gelatin capsule |
| 02/22/2000 | US6027742 Strongly resorbable, poorly crystalline apatitic calcium phosphate cement having an x-ray diffraction pattern similar to natural bone and a biocompatible supplemental material; grafting; prosthetics; plates; screws |
| 02/22/2000 | US6027734 To provide protection against pneumococcal colonization and systemic infection, intranasally administering a composition consisting essentially of pneumococcal surface protein a or a fragment containing a protection-eliciting epitope |
| 02/22/2000 | US6027732 Iscom or iscom-matrix comprising hydrophobic receptor molecules for antigenic substances |
| 02/22/2000 | US6027728 A selection of herbal powder for application to human skin to remove one layer and accelerate replacement; eczema; psoriasis; skin disorders; antiiflammatory agents; antiallergens |
| 02/22/2000 | US6027726 Liposome consisting essentially of a steric barrier molecule and a sulfhydryl-reactive lipid and attached to an oxidized antibody by a crosslinking agent having an acid hydrazide functionality on one end and a sulfhydryl on the other; drugs |
| 02/22/2000 | US6027721 Delivery of a biocompatible capsule comprising a core comprising living packaging cells that secrete a retroviral vector for infection of a target cell, comprising a heterologous gene encoding a biologically active molecule |
| 02/22/2000 | US6027715 Composition and means for treating dry mouth |
| 02/22/2000 | US6027714 Formulation for inhalation |
| 02/22/2000 | US6027713 Composition and method for the treatment of exercise induced pulmonary hemorrhage |
| 02/22/2000 | US6027712 Immunotherapy of inflammatory sinus and ear disease |
| 02/22/2000 | CA2258095C Tetrahydrolipstatin containing compositions |
| 02/22/2000 | CA2176713C Amphiphilic imidazolinium derivatives |
| 02/22/2000 | CA2164410C Emulsions as contrast agents and method of use |
| 02/22/2000 | CA2083385C Sustained release suppository |
| 02/22/2000 | CA2063819C Chewing gum composition with accelerated, controlled release of active agents |
| 02/22/2000 | CA2023563C Stable injectable pharmaceutical formulation for folic acid and leucovorin salts and method |
| 02/21/2000 | CA2244097A1 Pharmaceutical composition comprising bupropion hydrochloride and fumaric acid |
| 02/17/2000 | WO2000008092A1 Controlled release polyacrylic acid granules and a process for preparing the same |
| 02/17/2000 | WO2000008061A1 Reaction products of hyaluronic acid and natural amino acids and their use in cosmetic and pharmaceutical compositions |
| 02/17/2000 | WO2000008043A2 Prevention and treatment of viral disease |
| 02/17/2000 | WO2000008031A1 Novel phospholipids with unsaturated alkyl and acyl chains |
| 02/17/2000 | WO2000008004A1 Particle-forming compositions containing fused pyrrolocarbazoles |
| 02/17/2000 | WO2000007979A2 Compounds and compositions for delivering active agents |
| 02/17/2000 | WO2000007685A1 Method for producing spherical particles by crystallization |
| 02/17/2000 | WO2000007630A1 Nucleic acid delivery |
| 02/17/2000 | WO2000007627A2 Topical delivery systems for active agents |
| 02/17/2000 | WO2000007620A1 Protease inhibitors for use in the treatment of psoriasis |
| 02/17/2000 | WO2000007613A1 Remedies for cerebral central lesions with the use of neurotrophic factors |
| 02/17/2000 | WO2000007605A1 Use of camptothecin derivatives, with reduced gastrointestinal toxicity |
| 02/17/2000 | WO2000007603A2 End modified thermal responsive hydrogels |
| 02/17/2000 | WO2000007601A1 Ophtalmic solution with tetracycline for topical treatment of dry eye disease |
| 02/17/2000 | WO2000007597A1 Transmucosal therapeutic system for administering sildenafil |
| 02/17/2000 | WO2000007596A1 Water-soluble pharmaceutical formulation for administering sildenafil |
| 02/17/2000 | WO2000007595A1 Pyridinones for the treatment of sexual dysfunction |
| 02/17/2000 | WO2000007588A1 Pharmaceutical composition for injection based on paracetamol |
| 02/17/2000 | WO2000007581A2 Antioxidant, antiproliferous composition, comprising a carnitine and a carotenoid |
| 02/17/2000 | WO2000007577A2 Phosphatidylcholine as a medicament for the protection of mucosa |
| 02/17/2000 | WO2000007574A1 Medicinal products with retarded pharmacological activity and method for the production thereof |
| 02/17/2000 | WO2000007573A1 Composition with prolonged release of active principle capable of forming a micro-emulsion |
| 02/17/2000 | WO2000007572A2 Two-piece capsule for receiving pharmaceutical preparations for powder inhalers |
| 02/17/2000 | WO2000007571A2 Formulations having probiotically active microorganisms |
| 02/17/2000 | WO2000007570A1 Pharmaceutical compositions comprising ibuprofen and domperidone |
| 02/17/2000 | WO2000007569A1 Compressed compositions comprising clarified xanthan gum |
| 02/17/2000 | WO2000007568A1 Method for making coated gabapentine or pregabaline particles |
| 02/17/2000 | WO2000007567A1 Medicinal aerosol formulations |
| 02/17/2000 | WO2000007565A2 Methods of ophthalmic administration |
| 02/17/2000 | WO2000007549A1 Finely dispersed emulsifier-free systems of the oil-in-water and water-in-oil type, containing boron nitride |
| 02/17/2000 | WO2000007548A1 Finely dispersed emulsifier-free systems of the oil-in-water and water-in-oil type |
| 02/17/2000 | WO2000007531A1 Adhesive matrix type transdermal patch and method of manufacturing same |
| 02/17/2000 | WO2000002533A3 Dry-copying method for producing flat, individually dosed preparations of active agents |
| 02/17/2000 | WO1999065448A3 Cosmetic or dermopharmaceutical composition in the form of beads and methods for preparing same |
| 02/17/2000 | WO1999058116A3 Novel formulation containing paroxetine |
| 02/17/2000 | WO1999058113A3 Novel formulation containing paroxetine |
| 02/17/2000 | WO1999058107A8 Oral or mucosal preparation containing an active ingredient, with controlled active ingredient release, and its use |
| 02/17/2000 | WO1999056724A3 Therapeutic system for applying at least one care or active agent topically or transmucosally, on or through the nasal mucosa, and method for using the system |
| 02/17/2000 | WO1999055332A8 Medicinal compositions |
| 02/17/2000 | WO1999049909A9 Revascularization apparatus having coaxial channeling and injecting means |
| 02/17/2000 | WO1999020261A3 Use of antigunal agents for the topial treatment of fungus-induced mucositis |
| 02/17/2000 | DE19836960A1 Production of high-purity alginate useful for making capsules of encapsulating implants comprises extraction, sedimentation, filtration and precipitation |
| 02/17/2000 | DE19836646A1 Verwendung von N-Vinylpyrrolidon- und Vinylacetat-haltigen Copolymeren als Matrix zur Herstellung von festen, oralen pharmazeutischen und kosmetischen Zubereitungen Use of N-vinylpyrrolidone and vinyl acetate-containing copolymers as matrix for producing solid oral pharmaceutical and cosmetic preparations |
| 02/17/2000 | DE19835124A1 Production of starch esters particles useful as pharmaceutical excipient by spray drying an aqueous starch ester suspension |
| 02/17/2000 | DE19835123A1 Production of controlled-release pharmaceutical or agrochemical pellets or granules comprises short-time heating and stressing of mixture of starch ester and active ingredient(s) |
| 02/17/2000 | DE19830240C1 Wachsester mit vaselineähnlicher Konsistenz, Verfahren und Verwendung Wax esters with vaselineähnlicher consistency, process and |
| 02/17/2000 | CA2340020A1 Use of camptothecin derivatives, with reduced gastrointestinal toxicity |
| 02/17/2000 | CA2339485A1 Protease inhibitors for use in the treatment of psoriasis |
| 02/17/2000 | CA2339484A1 Pyridinones for the treatment of sexual dysfunction |
| 02/17/2000 | CA2339231A1 Topical delivery systems for active agents |
| 02/17/2000 | CA2338983A1 Prevention and treatment of viral disease |
| 02/17/2000 | CA2338173A1 Method for making coated gabapentine or pregabaline particles |
| 02/17/2000 | CA2338035A1 Antioxidant, antiproliferous composition, comprising a carnitine and a carotenoid |
| 02/17/2000 | CA2280449A1 Stabilized protein compositions |